Therehasbeenaremarkableincreaseininterestduring the past two decades in the relation between cardiovascular risk factors in children and the development of arteriosclerotic cardiovascular disease (ASCVD) and type 2 diabetes in adulthood. Initial studies concentrated on individual factors such as lipids and blood pressure. However, as research in this area has evolved and pediatricians have followed the lead of their colleagues in internal medicine, attention has turned to broader considerations of risk and, in particular, to obesity, insulin resistance and the metabolic syndrome. It is not surprising that these studies are affirming the concept that the roots of ASCVD and type 2 diabetes extend back into childhood.
The relation of obesity to ASCVD in adults is well known. Although children and adolescents do not have overt AS-CVD, obese children have a cardiovascular risk profile consistent with its early development, i.e., significantly higher blood pressure, triglycerides and fasting insulin and significantly lower HDL-C. 1 Moreover, the degree of risk increases with increasing obesity. 2 The result is early deposition of fatty streaks and plaque in adolescent coronary arteries, 3 and the outcome in adulthood is an increased incidence of premature cardiovascular and all-cause mortality in individuals who were obese adolescents. 4 Despite a perception in the general population that overweight children tend to become thinner as they go through adolescence and maintain the thinness as they become young adults, longitudinal growth studies have shown a highly significant (r = 0.61) correlation in body mass index (BMI) between ages 7 and 24, and have further shown that BMI at age 7 predicts the ASCVD risk factors at age 24. 5 The relevance of these findings is of increasing importance to pediatricians, since the prevalence of obesity in children is steadily increasing in all ethnic groups. 6 The relation of obesity to insulin resistance is also well known, and while insulin resistance is related to the development of ASCVD, its role independent from obesity is not cle- In an attempt to clarify the independent influence of BMI and insulin resistance on the development of cardiovascular risk and type 2 diabetes, we have been conducting a longitudinal study, including euglycemic hyperinsulinemic clamps, in children who were randomly recruited from a public school population of 11-14 year olds. Results from this study are showing that insulin resistance, of itself, is associated with increased levels of cardiovascular risk factors. 1 When the cohort was divided into two groups according to insulin sensitivity and resistance, the insulin resistant group was found to have significantly higher fasting insulin, triglycerides and lower HDL-C, independent of BMI. And, when the cohort was further divided according to levels of both BMI and insulin resistance, an interaction was uncovered in the obese, insulin resistance group, leading to higher levels of risk factors than would be expected by simply adding together the individual effects of BMI and insulin resistance. This cohort has now been followed to early young adulthood (age range 18-21). Recent studies 7 have shown that insulin resistance measured at age 13 predicts, independent from BMI, blood pressure and lipids at age 19. Thus, it * MD, Professor, Department of Pediatrics, University of Minnesota, Twin Cities, MN, USA. ♦ Obesity, insulin resistance and the metabolic syndrome -Sinaiko A appears that insulin resistance, of itself, is etiologically related to the ultimate development of ASCVD.
As investigation into the relation between obesity and insulin resistance has intensified, certain fat compartments, in particular visceral fat, have been shown to be more functionally active than others. 8 Can fasting insulin be used as a surrogate measure for insulin resistance? Unfortunately, the range of fasting insulin in children is relatively narrow, so that it also lacks the precision required to categorize individuals. However, degree of insulin secretion is relevant to the study of insulin resistance, and fasting insulin levels may be used in other ways. For instance, it has been incorporated by the European Group for the Study of Insulin Resistance into the definition for the metabolic syndrome. 13 In our studies in children we have incorporated it with triglycerides, HDL-C and blood pressure into an "insulin resistance score" that has been applied in studies of BMI and insulin resistance. 1 We have found that the score may provide a better picture of overall cardiovascular risk than examination of the individual risk factors.
Physicians caring for children have historically been en- 
